Developing hypothetical inhibition mechanism of novel urea transporter b inhibitor

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Li, Min ^a   Tou, Weng Ieong ^b   Zhou, Hong ^a   Li, Fei ^a,c   Ren, Huiwen ^a   Chen, Calvin Yu Chian ^b,d,e,f   Yang, Baoxue ^a  

^a PEKING UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; PROTEIN BINDING; UREA TRANSPORTER;

AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; ERYTHROCYTE; HUMAN; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DRUG DESIGN; ERYTHROCYTES; HUMANS; HYDROGEN BONDING; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS;

EID: 84905284058     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05775     Document Type: Article

References (44)

1. Tsukaguchi, H. et al. Cloning and characterization of the urea transporter UT3: localization in rat kidney and testis. J Clin Invest 99, 1506-15 (1997)
2. Couriaud, C., Ripoche, P. & Rousselet, G. Cloning and functional characterization of a rat urea transporter: expression in the brain. Biochim Biophys Acta 1309, 197-9 (1996)
3. Timmer, R. T. et al. Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues. Am J Physiol Cell Physiol 281, C1318-25 (2001)
4. Liu, Y. et al. 1,1-Difluoroethyl-substituted triazolothienopyrimidines as inhibitors of a human urea transport protein (UT-B): new analogs and binding model. Bioorg Med Chem Lett 23, 3338-41
5. Bankir, L., Bouby, N., Trinh-Trang-Tan, M. M., Ahloulay, M. & Promeneur, D. Direct and indirect cost of urea excretion. Kidney Int 49, 1598-607 (1996)
6. Bankir, L. & Yang, B. New insights into urea and glucose handling by the kidney, and the urine concentrating mechanism. Kidney Int 81, 1179-98 (2012)
7. Sands, J. M. Mammalian urea transporters. Annu Rev Physiol 65, 543-66 (2003)
8. Promeneur, D. et al. Evidence for distinct vascular and tubular urea transporters in the rat kidney. J Am Soc Nephrol 7, 852-60 (1996)
9. Cafferkey, R. et al. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol 13, 6012-23 (1993)
10. Yang, B., Bankir, L., Gillespie, A., Epstein, C. J. & Verkman, A. S. Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B. J Biol Chem 277, 10633-7 (2002)
11. Bankir, L., Chen, K. & Yang, B. Lack of UT-B in vasa recta and red blood cells prevents urea-induced improvement of urinary concentrating ability. Am J Physiol Renal Physiol 286, F144-51 (2004)
12. Yang, B. & Verkman, A. S. Analysis of double knockoutmice lacking aquaporin-1 and urea transporter UT-B. Evidence for UT-B-facilitated water transport in erythrocytes. J Biol Chem 277, 36782-6 (2002)
13. Fenton, R. A., Chou, C. L., Stewart, G. S., Smith, C. P. & Knepper, M. A. Urinary concentrating defect in mice with selective deletion of phloretin-sensitive urea transporters in the renal collecting duct. Proc Natl Acad Sci U S A 101, 7469-74 (2004)
14. Lei, T. et al. Role of thin descending limb urea transport in renal urea handling and the urine concentrating mechanism. Am J Physiol Renal Physiol 301, F1251-9 (2011)
15. Liu, Y. et al. 1,1-Difluoroethyl-substituted triazolothienopyrimidines as inhibitors of a human urea transport protein (UT-B): new analogs and binding model. Bioorg Med Chem Lett 23, 3338-41 (2013)
16. Sands, J. M. Urea transporter inhibitors: en route to new diuretics. Chem Biol 20, 1201-2 (2013)
17. Yao, C. et al. Triazolothienopyrimidine inhibitors of urea transporter UT-B reduce urine concentration. J Am Soc Nephrol 23, 1210-20 (2012)
18. Knepper, M. A. & Miranda, C. A. Urea channel inhibitors: a new functional class of aquaretics. Kidney Int 83, 991-3 (2013)
19. Levin, E. J. et al. Structure and permeation mechanism of a mammalian urea transporter. Proc Natl Acad Sci U S A 109, 11194-9 (2012)
20. Levin, E. J., Quick, M.&Zhou, M. Crystal structure of a bacterial homologue of the kidney urea transporter. Nature 462, 757-61 (2009)
21. Li, F. et al. A novel small-molecule thienoquinolin urea transporter inhibitor acts as a potential diuretic. Kidney Int 83, 1076-86 (2013)
22. Salituro, G. M. et al. Meridamycin: A novel nonimmunosuppressive FKBP12 ligand from streptomyces hygroscopicus. Tetrahedron Letters 36, 997-1000 (1995)
23. Boeckmann, B. et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 31, 365-70 (2003)
24. Henikoff, S. & Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A 89, 10915-9 (1992)
25. Lovell, S. C. et al. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins-Structure Function and Bioinformatics 50, 437-50 (2003)
26. Eisenberg, D., Luthy, R. & Bowie, J. U. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol 277, 396-404 (1997)
27. Mazeron, P., Didelon, J., Muller, S. & Stoltz, J. F. A theoretical approach of the measurement of osmotic fragility of erythrocytes by optical transmission. Photochem Photobiol 72, 172-8 (2000)
28. Sharpless, K. B. et al. The osmium-catalyzed asymmetric dihydroxylation: a new ligand class and a process improvement. The Journal of Organic Chemistry 57, 2768-2771 (1992)
29. Brooks, C. Assessing, improving and using grid-based docking algorithms in CHARMM. Abstracts of Papers of the American Chemical Society 233, 285-285 (2007)
30. Brooks, B. R. et al. Charmm - a Program for Macromolecular Energy, Minimization, and Dynamics Calculations. Journal of Computational Chemistry 4, 187-217 (1983)
31. Venkatachalam, C. M., Jiang, X., Oldfield, T. & Waldman, M. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics & Modelling 21, 289-307 (2003)
32. Hao, M. H., Haq, O. & Muegge, I. Torsion angle preference and energetics of small-molecule ligands bound to proteins. J Chem Inf Model 47, 2242-52 (2007)
33. Gehlhaar, D. K. et al. Molecular Recognition of the Inhibitor Ag-1343 by Hiv-1 Protease - Conformationally Flexible Docking by Evolutionary Programming. Chemistry & Biology 2, 317-324 (1995)
34. Chang, Y. S. et al. Stapled a-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy. Proceedings of the National Academy of Sciences 110, E3445-E3454.
35. So, S. S. & Karplus, M. Evolutionary optimization in quantitative structureactivity relationship: an application of genetic neural networks. J Med Chem 39, 1521-30 (1996)
36. Rogers, D. & Hopfinger, A. J. Application of Genetic Function Approximation to Quantitative Structure-Activity-Relationships and Quantitative Structure- Property Relationships. Journal of Chemical Information and Computer Sciences 34, 854-866 (1994)
37. Slinker, B. K. & Glantz, S. A. Multiple linear regression - Accounting for multiple simultaneous determinants of a continuous dependent variable. Circulation 117, 1732-1737 (2008)
38. Chang, C. C. & Lin, C. J. LIBSVM: A Library for Support Vector Machines. Acm Transactions on Intelligent Systems and Technology 2 (2011)
39. Stanton, D. T. QSAR and QSPR Model Interpretation Using Partial Least Squares (PLS) Analysis. Current Computer-Aided Drug Design 8, 107-127 (2012)
40. Sapay, N. & Tieleman, D. P. Combination of the CHARMM27 Force Field with United-Atom Lipid Force Fields. Journal of Computational Chemistry 32, 1400-1410 (2011)
41. Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13, 1299-307 (2007)
42. Fadden, P. et al. Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90. Chemistry & Biology 17, 686-694 (2010)
43. Sun, Y. X. & Kollman, P. A. Hydrophobic Solvation of Methane and Nonbond Parameters of the Tip3p Water Model. Journal of Computational Chemistry 16, 1164-1169 (1995)
44. Huggins, J. P., Pelton, J. T. & Miller, R. C. The structure and specificity of endothelin receptors: Their importance in physiology and medicine. Pharmacology & Therapeutics 59, 55-123 (1993)